Injectable sumatriptan: now needle-based or needle-free.
Rothrock
John F
JF
Headache Treatment and Research Program, University of Alabama, Birmingham, AL, USA.
D000075202:Contraindications; D004333:Drug Administration Routes; D016503:Drug Delivery Systems / Q000295:instrumentation* / Q000379:methods* / Q000639:trends; D006801:Humans; D007279:Injections, Subcutaneous / Q000295:instrumentation / Q000379:methods; D008881:Migraine Disorders / Q000188:drug therapy*; D009339:Needles / Q000009:adverse effects; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D018170:Sumatriptan / Q000008:administration & dosage* / Q000009:adverse effects; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology
D017366:Serotonin Receptor Agonists; D018170:Sumatriptan